Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.
| Image |  |
|---|---|
| Description | scientific article published on 5 November 2012 |
| Author/s |
author: Guido Marcucci Martha Wadleigh Clara D. Bloomfield Eyal C Attar Philip C Amrein Richard M Stone Jonathan E Kolitz Eunice S Wang Gerard Lozanski Bayard L Powell Richard A. Larson |
| Publication date | November 5, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |